Abivax ADR

ABVXNASDAQ · USD
98.87USD+0.37 (+0.38%)
227

Abivax ADR (ABVX) Unusual Options Activity Today

ABVX options volume power reached 197x on the previous trading day. The highest reading was on the $93 CALL expiring 2026-10-02.

Read more

Checking ABVX unusual options activity helps you spot when traders are making outsized bets on Abivax ADR before the broader market catches on. Abivax ADR's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ABVX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ABVX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ABVX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ABVX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.

In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.

Catalysts rarely arrive without a footprint, and ABVX unusual options activity is often where that footprint shows up first. Our scanner tracks Abivax ADR's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ABVX unusual options volume on the call side or chasing put sweeps, Abivax ADR's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-02
Calls
73.0023.6027.6025.60168%21200.00%
96.002.655.504.0879%105200.00%
90.007.4010.308.8584%4023173.91%
98.001.454.302.8878%1915126.67%
80.0016.6020.1018.3525%22100.00%
Puts
87.00—1.201.20158%214151.22%
96.000.203.401.8087%112250.00%
118.0017.8021.5019.65122%1250.00%
85.00—0.200.20109%8619145.03%
84.00—0.150.15109%327741.56%

As of September 29, 2026

Spot unusual options activity before it moves

Track ABVX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial